In the mouse intestinal epithelium, simultaneous mutation of APC and KRAS strongly dysregulates metabolism, enhancing glutamine consumption; thus, the glutamine antiporter SLC7A5 is essential for the development of colorectal tumors 125. Here, KRAS is linked to colorectal neoplasm.